臨床外科67巻11号

2012年10月発行

特集 外科医のための癌診療データ

臓器別最新データ 8．膵癌

膵癌の疫学

著者： 砂村眞琴¹ 河地茂行¹ 島津元秀¹

所属機関： ¹東京医科大学八王子医療センター消化器外科・移植外科

ページ範囲：P.214 - P.221

文献概要

覚えておきたいデータ

◆膵癌による死者は28,815人（2011年）で，継続的に増加しており，男性死因の第5位，女性死因の第4位である．

◆膵癌患者の7～10％は家族歴があり，家族性膵癌（第一度近親者に2名以上膵癌患者がいる）では膵癌のリスクが9倍になる．

◆喫煙は膵癌発症の危険率を増加させ，25～30％は喫煙が原因，禁煙で膵癌の22％は予防できる．

参考文献

1）日本膵臓学会膵癌登録委員会：膵癌登録報告2007．膵臓22：e1-e94，2007

2）平成23年人口動態統計年計（概数）の概況．http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/geppo/nengai11/dl/gaikyou23.pdf

3）平成22年（2010）人口動態統計（確定数）の概況．http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei10/index.html

4）複数部位の集計-年次推移-（独立行政法人国立がん研究センターがん対策情報センター）．http://ganjoho.jp/pro/statistics/gdb_trend.html

5）全国がん罹患モニタリング集計（独立行政法人国立がん研究センターがん対策情報センター）．http://ganjoho.jp/professional/statistics/statistics.html

6）がん死亡率の5か国比較（独立行政法人国立がん研究センターがん対策情報センター）．http://ganjoho.jp/professional/statistics/digest/index.html

7）日本膵臓学会膵癌診療ガイドライン改訂委員会（編）：科学的根拠に基づく膵癌診療ガイドライン．2009年版．金原出版，2009，p49

8）Wolpin BM, Chan AT, Hartge P, et al：ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 101：424-431, 2009

9）Petersen GM, de Andrade M, Goggins M, et al：Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 15：704-710, 2006

10）Klein AP, Brune KA, Petersen GM, et al：Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64：2634-2638, 2004

11）Tersmette AC, Petersen GM, Offerhaus GJ, et al：Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 7：738-744, 2001

12）Schenk M, Schwartz AG, O'Neal E, et al：Familial risk of pancreatic cancer. J Natl Cancer Inst 93：640-644, 2001

13）Matsubayashi H, Maeda A, Kanemoto H, et al：Risk factors of familial pancreatic cancer in Japan：current smoking and recent onset of diabetes. Pancreas 40：974-978, 2011

14）Brune KA, Lau B, Palmisano E, et al：Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst 102：119-126, 2010

15）Hahn SA, Greenhalf B, Ellis I, et al：BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95：214-221, 2003

16）DiMagno EP, Reber HA, Tempero MA：AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 117：1464-1484, 1999

17）Gullo L, Pessilli R, Morselli-Labate AM：Coffee and cancer of the pancreas：an Italian multicenter study. The Italian Pancreatic Cancer Study Group. Pancreas 11：223-229, 1995

18）Whitcomb DC, Applebaum S, Martin SP：Hereditary pancreatitis and pancreatic cancer. An NY Acad Sci 880：201-209, 1999

19）Lynch HT, Brand RE, Lynch JF, et al：Hereditary factors in pancreatic cancer. J Hepatobiliary Pancreat Surg 9：12-31, 2002

20）北川元二：膵癌のリスクファクター慢性膵炎．肝胆膵48：561-567，2004

21）大槻　眞：慢性膵炎長期予後調査．厚生労働省難治性疾患克服研究事業　難治性膵疾患に関する調査研究平成16年度報告書．アークメディア東京，2005，pp151-156

22）Lowenfels AB, Maisonneuve P, Cavallini G, et al；the International Pancreatitis Study Group：Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328：1433-1437, 1993

23）小俣政男：難治癌に挑む―若き消化器医へのメッセージ．日消誌106：1141-1146，2009

Go VLW, et al（eds）；The exocrine pancreas biology, pathology and disease. New York, Raven Press, 1986, pp829-839

25）Hengstler JG, Bauer A, Wolf HK, et al：Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer. American Res 20：2967-2974, 2000

26）Teich N, Schulz HU, Witt H, et al：N34S, a pancreatitis associated SPINK1 mutation, is not associated with sporadic pancreatic cancer. Pancreatology 3：67-68, 2003

27）Huxley R, Ansary-Moghaddam ABerrington de Gonzalez A, et al：Type-Ⅱ diabetes and pancreatic cancer：a meta-analusis of 36 studies. Br J Cancer 92：2076-2083, 2005

28）Huxley R, Ansary-Moghaddam A, Berrington de González A, et al：Type-Ⅱ diabetes and pancreatic cancer：a meta-analysis of 36 studies. Br J Cancer 92：2076-2083, 2005

29）Gullo L：Diabetes and the risk of pancreatic cancer. Ann Oncol 10（Suppl 4）：s79-81, 1999

30）Silverman DT, Schiffman M, Everhart J, et al：Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80：1830-1837, 1999

31）Calle EE, Murphy TK, Rodriguez C, et al：Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control 9：403-410, 1998

32）Lin Y, Tamakoshi A, Kawamura T, et al for the JACC Study Group：A prospective cohort study of cigarette smoking and pancreatic cancer in Japan. Cancer Causes Control 13：249-254, 2002

33）Stolzenberg-Solomon RZ, Graubard BI, Chari S, et al：Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294：2872-2878, 2005

34）Gallicchio L, Kouzis A, Genkinger JM, et al：Active cigarette smoking, household passive smoke exposure, and the risk of developing pancreatic cancer. Prev Med 42：200-205, 2006

35）Fuchs CS, Colditz GA, Stampfer MJ, et al：A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 156：2255-2260, 1996

36）Nakamura K, Nagata C, Wada K, et al：Cigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death：a prospective cohort study in Japan. Jpn J Clin Oncol 41：225-231, 2011

37）Matsuo K, Ito H, Wakai K, et al：Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. Cigarette smoking and pancreas cancer risk：an evaluation based on a systematic review of epidemiologic evidence in the Japanese population. Jpn J Clin Oncol 41：1292-1302, 2011

38）Prokopczyk B, Hoffmann D, Bologna M, et al：Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 15：677-685, 2002

39）Al-Wadei HA, Schuller HM：Nicotinic receptor-associated modulation of stimulatory and inhibitory neurotransmitters in NNK-induced adenocarcinoma of the lungs and pancreas. J Pathol 218：437-445, 2009

40）Calle EE, Rodriguez C, Walker-Thurmond K, et al：Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med 348：1625-1638, 2003

41）de Vos tot Nederveen Cappel WH, Lagendijk MA, Lamers CB, et al：Surveillance for familial pancreatic cancer. Scand J Gastroenterol 239：94-99, 2003

42）Nishi M, Ohba S, Hirata K, et al：Dose-response relationship between coffee and the risk of pancreas cancer. Jpn J Clin Oncol 26：42-48, 1996

43）Michaud DS, Giovannucci E, Willett WC, et al：Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 10：429-437, 2001

44）Thiébaut AC, Jiao L, Silverman DT, et al：Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst 101：1001-1011, 2009

45）Larsson SC, Bergkvist L, Wolk A：Consumption of sugar and sugar-sweetened foods and the risk of pancreatic cancer in a prospective study. Am J Clin Nutr 84：1171-1176, 2006

46）Japan Pancreas Society：Japan Pancreatic Cancer Registry；30th Year Anniversary. Pancreas（in press）

47）Kimura Y, Imai K, Shimamura K, et al：Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in the patients with advanced pancreatic carcinoma. Pancreas 41：195-205, 2012

48）Sugimoto M, Wong DT, Hirayama A, et al：Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6：78-95, 2010